Deep hierarchical subtyping of multi-organ systemic sclerosis trajectories - a EUSTAR study
Cécile Trottet(University of Zurich), Claudia Ickinger(University of the Witwatersrand), I. Castellví(Hospital de Sant Pau), Jörg Henes(University of Tübingen), Joško Mitrović(University Hospital Dubrava), Florenzo Iannone(University of Bari Aldo Moro), Ahmed E. Allam(University of Zurich), Alexandra Balbir‐Gurman(Technion – Israel Institute of Technology), N Hunzelmann, Francesco Paolo Cantatore(University of Foggia), Carlomaurizio Montecucco(University of Pavia), Ivan Foeldvari(Center for Rheumatology), L. Petelytska(University of Zurich), Michael Krauthammer(University of Zurich), Marta Dzhus(Bogomolets National Medical University), Maurizio Cutolo(Ospedale Policlinico San Martino), Gianluca Moroncini(Marche Polytechnic University), Elena Rezuş(Grigore T. Popa University of Medicine and Pharmacy), Przemysław Kotyla(Medical University of Silesia), Bojana Stamenković, Katja Perdan Pirkmajer(Marche Polytechnic University), Paolo Airó(University of Lisbon), Marie‐Elise Truchetet(Centre National de la Recherche Scientifique), Jeska de Vries‐Bouwstra(Leiden University Medical Center), Jelena Čolić(Universitätsklinikum Tübingen), Simona Rednic(Charité - Universitätsmedizin Berlin), Madelon C Vonk(Radboud University Nijmegen), Yannick Allanore(Inserm), Silvia Bellando-Randone(Azienda Ospedaliero-Universitaria Careggi), Luca Idolazzi(University of Verona), Oliver Distler(University Hospital of Zurich), Patrícia Carreira, Radim Bečvář(Charles University), Manuel Schürch(Harvard University), Maria De Santis(Medical University of Vienna), Tânia Santiago(University of Coimbra), Mislav Radić, Gabór Kumánovics, Giovanna Cuomo(Regione Campania), Carmen Pilar Simeón‐Aznar(Vall d'Hebron Hospital Universitari), Gianluigi Bajocchi(Hospitais da Universidade de Coimbra), Elisabetta Zanatta(University of Padua), Christopher P. Denton(The Royal Free Hospital), Anna‐Maria Hoffmann‐Vold(University of Oslo), Magda Pârvu(Spitalul Clinic Colentina), Ulrich A. Walker(University Hospital of Basel)
Cited by 5
Related Papers
Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2020|786
Mapping and predicting mortality from systemic sclerosis
|Annals of the Rheumatic Diseases|2017|699
Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
|Journal of the American Academy of Dermatology|2008|597
<i>MUC5B</i> Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
|New England Journal of Medicine|2018|501
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
|Annals of the Rheumatic Diseases|2014|432